Mable Therapy has secured funding
Mable Therapy has raised funds from Gresham House Ventures, a growth equity investor specializing in digitally driven businesses, to further build out its proprietary technology platform, as well as invest in sales and marketing capabilities, helping take the business to its next stage of growth.
Mable Therapy is the UK’s leading digital platform for children’s speech and language therapy and counselling services. Using cutting-edge, gamified technology, Mable Therapy’s interactive platform captivates children and young people from the moment they start their session. The platform uses creative resources, games and tools to reduce anxiety and make therapy engaging and fun.
Oaklins Cavendish, based in the UK, advised Mable Therapy on its investment from Gresham House Ventures.
Talk to the deal team
Related deals
Den Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Learn moreTekova Oyj has completed a technical listing on the Nasdaq First North Growth Market Finland
Tekova Oyj has successfully completed a technical listing (IPO) on the Nasdaq First North Growth Market Finland. This transaction marks a significant milestone in the company’s growth strategy, enhancing its visibility and access to capital markets.
Learn moreBayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Learn more